All Relations between Mood Disorders and Trazodone
| Publication | Sentence | Publish Date | Extraction Date | Species |
|---|---|---|---|---|
| Calogero Crapanzano, Ilaria Casolaro, Anna Julia Krup. Clinical experience with parenteral trazodone in mood disorders: A literature review. Psychiatria polska. vol 58. issue 3. 2024-09-01. PMID:39217422. | our narrative review summarizes pharmacological properties and clinical data concerning use of parenteral trazodone in mood disorders. | 2024-09-01 | 2024-09-04 | Not clear |
| Calogero Crapanzano, Ilaria Casolaro, Anna Julia Krup. Clinical experience with parenteral trazodone in mood disorders: A literature review. Psychiatria polska. vol 58. issue 3. 2024-09-01. PMID:39217422. | clinical experience with parenteral trazodone in mood disorders: a literature review. | 2024-09-01 | 2024-09-04 | Not clear |
| Magdalena Świądro-Piętoń, Dominika Dudek, Renata Wietecha-Posłuszn. Direct Immersion-Solid Phase Microextraction for Therapeutic Drug Monitoring of Patients with Mood Disorders. Molecules (Basel, Switzerland). vol 29. issue 3. 2024-02-10. PMID:38338419. | it has been adapted to identify the most commonly used drugs in mood disorders, including amitriptyline, citalopram, fluoxetine, paroxetine, sertraline, trazodone, duloxetine, venlafaxine, lamotrigine, quetiapine, olanzapine, and mirtazapine. | 2024-02-10 | 2024-02-12 | Not clear |
| F M Jacobse. Low-dose trazodone as a hypnotic in patients treated with MAOIs and other psychotropics: a pilot study. The Journal of clinical psychiatry. vol 51. issue 7. 1990-08-13. PMID:2365668. | similarly, 26 of 27 mood disorder patients with insomnia unrelated to maois reported improved sleep with low-dose trazodone. | 1990-08-13 | 2023-08-11 | Not clear |